Danish Naveed, Riaz Anwar Khan, Abdul Malik, Syed Zahid Ali Shah, Ikram Ullah, Amjad Hussain


Background: Cardiopulmonary bypass (CPB) is associated with morbidity and mortality. To reduce its adverse effect modified ultrafiltration is being increasingly employed. This study is planned to evaluate the benefits of modified ultrafiltration (MUF) in adult cardiac surgery. Methods: Eighty consecutive patients presenting to adult cardiac surgery as elective case were enrolled. These patients were randomly divided in to two groups. MUF group which received modified ultrafiltration after separation from CPB and control group which did not receive modified ultrafiltration. Postoperative mediastinal and chest drainage in 24 hrs, blood products requirement, reopening, ICU stay, and mortality in 30 days were recorded. These variables were compared between MUF group and control group. Results:  Forty patients were randomized to control group and 40 in MUF group. Mean age was 51.15±8.90 in control group as compared to 46.95±13.24 MUF group (p=0.1). Out of 40 patients in control group 7 (17.5%) were female while 11 (27.5%) out of total 40 were female in MUF group. (p=.284). Mean CBP time was 120.62±20.97 in control group versus 117.37±38.78 in MUF group (p=0.64). Post-operative drain output ranged from 330 ml to 1300 ml in control group and 300 ml to 780 ml in MUF group. Mean postoperative drain output 554.25±192.57 in control group versus 439.22±89.59 in MUF group (p=.001). Three (7.5%) out of 40 patients required re-exploration in control group versus 1 (2.5%) in MUF group. (p=.305). Mean ICU stay was 52.80±22.37 hours in control group versus 45.30±21.82 hours in MUF group (p=0.133). Three (7.5%) out of 40 patients died in control group versus 1 (2.5%) in MUF group. (p=0.305). Conclusion: Use of modified ultrafiltration is associated with low postoperative bleeding less requirements of blood and blood products.   


Full Text:



Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation:pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232–244.

Hashimoto K, Miyamoto H, Suzuki K, Horikoshi S, Matsui M, Arai T, et al. Evidence of organ damage after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992;104(3):666–73.

Ferraris VA, Ferraris SP, Saha SP, Hessel EA II, Haan CK, Royston BD. et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline. Ann Thorac Surg 2007;83(5):S27–86.

Currie CJ, Patel TC, McEwan P, Dixon S. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfus Med 2004;14:19–24.

Torina AG, Petrucci O, Oliveira PP, Severino ES, Vilarinho KA, Lavagnoli CF et al. The effects of modified ultrafiltration on pulmonary function and transfusion equirements in patients underwent coronary artery bypass graft surgery. Rev Bras Cir Cardiovasc 2010;25(1):59–65.

Papadopoulos N, Bakhtiary F, Grün V, Weber CF, Strasser C, Moritz A. The effect of normovolemic modified ultrafiltration on inflammatory mediators, endotoxins, terminal complement complexes and clinical outcome in high-risk cardiacsurgery patients. Perfusion 2013;28(4):306–14.

Luciani GB, Menon T, Vecchi B, Auriemma S, Mazzucco A. Modified ultrafiltration reduces morbidity after adult cardiac operations: prospective, randomized clinical trial. Circulation 2001;104(1):I253–9.

Groom RC, Froebe S, Martin J, Manfra MJ, Cormack JE, Morse C, et al. Update on pediatric perfusion practice in North America: 2005 survey. J Extra Corpor Technol 2005;3794):343–50.

Murphy PJ, Connery C, Hicks GL Jr, Blumberg N. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1992;104(4):1092–9.

Patel NN, Avlonitis VS, Jones HE, Reeves BC, Sterne JA, Murphy GJ. Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis. Lancet Haematol 2015;2(12):e543–53.

Boodwani M, Williams K, Babaev A, Gill G, Saleem N, Rubens FD. Ultrafiltration reduces blood transfusion following cardiac surgery: a meta-analysis. Eur J Cardiothorac Surg 2006;30(6):892–7.

Torina AG, Silveira-Filho LM, Vilarinho KA, Eghtesady P, Oliveira PP, Sposito AC et al. Use of modified ultrafiltration in adults undergoing coronary artery bypass grafting is associated with inflammatory modulation and less postoperative blood loss: a randomized and controlled study. J Thorac Cardiovasc Surg 2012;144(4):663–70.

Zahoor M, Abbass S, Khan AA, Ahmad SA. Modified Ultrafiltration: role in adult cardiac surgical hemostasis. J Ayub Med Coll Abottabad 2007;19(4):49–54.

Abbas S, Bakhsh M, Naqvi SMS, Saddique N. Modified ultrafiltration in adult cardiac surgery is it really beneficial? a pospective randomized clinical trial. Professional Med J 2007;14(4):653–8.

Bogă M, Islamoglu, Badak I, Cikirikçioglu M, Bakalim T, Yagdi T, et al. The effects of modified hemofiltration on inflammatory mediators and cardia performance in coronary artery bypass grafting. Perfusion 2000;15(2):143–50.

Koutlas TC. Gaynor JW, Nocolson SC, Steven JM, Wernovsky G, Spray TL. Modified ultrafiltration reduces postoperative morbidity after cavopulmonary connection. Ann Thorac Surg 1997;64(1):37–42.

Khanna MP, Hebert PC, Fergusson DA. Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. Transfus Med Rev 2003;17(2):110–9.

Grünenfelder J, Zünd G, Schoeberlein A, Maly FE, Schurr U, Guntli S, et al. Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults. Eur J Cardiothorac Surg 2000;17(1):77–83.


  • There are currently no refbacks.

Contact Number: +92-992-382571

email: [jamc] [@] []